SFX by Ex Libris Inc.

Title:	Nemo-like kinase, a multifaceted cell signaling regulator
Source:	Cellular Signalling [0898-6568] Ishitani, Tohru yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Shen, Q. "MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer." Cancer letters 344.2 (2013): 204-11.
description	2.	Wang, Y. "Linear ubiquitination of NEMO brakes the antiviral response." Cell host & microbe 12.2 (2012): 129-131.
description	3.	Zanotti, S. "Nemo-like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling." Journal of cellular biochemistry 113.2 (2011): 449-456.
description	4.	Wang, L. "miR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2." Oncology Reports 32.1 (2014): 261-9.
description	5.	Huang, Y. "The emerging role of Nemo-like kinase (NLK) in the regulation of cancers." Tumor Biology 36.12 (2015): 9147-9152.
description	6.	Xu, L. "MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity." Journal of hepatology 60.3 (2014): 590-598.
description	7.	Zhang, T. "miR-101 Inhibits Cholangiocarcinoma Angiogenesis through Targeting Vascular Endothelial Growth Factor (VEGF)." The American journal of pathology 182.5 (2013): 1629-1639.
description	8.	Furuta, M. "The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma." PLoS ONE 8.3 (2013).
description	9.	BELGNAOUI, S. "Linear Ubiquitination of NEMO Negatively Regulates the Interferon Antiviral Response through Disruption of the MAVS-TRAF3 Complex." Cell host & microbe 12.2 (2012): 211-222.
description	10.	Nagao, K. "Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons." Genomics 85.4 (2005): 462-71.
description	11.	Deng, L. "Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain." Cell 103.103 (2000): 351-61.
description	12.	Kang, S. "WNT signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing c/EBPalpha and PPARgamma." The Journal of biological chemistry 282.19 (2007): 14515-24.
description	13.	Strillacci, A. "Loss of miR-101 Expression Promotes Wnt/β-Catenin Signalling Pathway Activation and Malignancy in Colon Cancer Cells." The Journal of pathology 229.3 (2012): 379-389.
description	14.	Birchmeier, C. "Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic -cell function." EMBO journal 34.10 (2015): 1417-1433.
description	15.	Launer, K. "GWAS for executive function and processing speed suggests involvement of the CADM2 gene." Molecular Psychiatry 21.2 (2015): 189-197.
description	16.	Crespo-Barreto, J. "Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis." PLoS Genetics 6.7 (2010).
description	17.	Yamamoto, M. "Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling." Nature immunology 7.9 (2006): 962-70.
description	18.	ZOU, X. "miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells." Molecular Medicine Reports 13.1 (2016): 994-1002.
description	19.	"NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells." Molecular and cellular biochemistry. 369.1: 27-33.
description	20.	"Wip1 directly dephosphorylates NLK and increases Wnt activity during germ cell development." Biochimica et biophysica acta. 1863.4: 1013-1022.